Vident Investment Advisory, LLC Zai Lab LTD Transaction History

Vident Investment Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $130,607 - $250,294	-2,379 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $21,210 - $36,030	202 Added 9.28%	2,379 $251,000
Q1 2021 May 14, 2021	SELL	$126.27 - $191.71 $110,738 - $168,129	-877 Reduced 28.72%	2,177 $290,000
Q4 2020 Feb 08, 2021	SELL	$81.94 - $135.34 $819 - $1,353	-10 Reduced 0.33%	3,054 $413,000
Q3 2020 Nov 12, 2020	SELL	$73.3 - $89.48 $324,792 - $396,485	-4,431 Reduced 59.12%	3,064 $255,000
Q2 2020 Jul 17, 2020	BUY	$48.82 - $82.53 $10,789 - $18,239	221 Added 3.04%	7,495 $615,000
Q1 2020 May 12, 2020	SELL	$39.1 - $62.9 $75,150 - $120,893	-1,922 Reduced 20.9%	7,274 $375,000
Q4 2019 Feb 11, 2020	BUY	$29.79 - $43.06 $80,224 - $115,960	2,693 Added 41.41%	9,196 $382,000
Q3 2019 Nov 13, 2019	BUY	$30.47 - $37.65 $198,146 - $244,837	6,503 New	6,503 $210,000

130

49.9M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.69B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.